Euro vs US Dollar

Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.

Registrieren

PALI Palisade Bio Inc

0,8479

0,0109 (1,30%)

08 Mär 2025 - Geschlossen

Verzögert um 15 Minuten

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses

Palisade Bio (NASDAQ:PALI)
Historical Stock Chart
Von Feb 2025 bis Mär 2025

Click Here for more Palisade Bio Charts.

Palisade Bio (NASDAQ:PALI)
Historical Stock Chart
Von Mär 2024 bis Mär 2025

Click Here for more Palisade Bio Charts.

News Palisade Bio Inc

Palisade Bio Participates in Virtual Investor “What This Means” Segment
Dienstag 4 März 2025 (5 Tage vor) • GlobeNewswire Inc.

Palisade Bio, Inc. Announces Receipt of Cash Proceeds from Canada’s SR&ED Tax Incentive Program for Reimbursement of Development Costs of PALI-2108 for Treatment of Ulcerative Colitis (UC)
Donnerstag 20 Februar 2025 (2 Wochen vor) • GlobeNewswire Inc.

Palisade Bio, Inc. Participates in the Virtual Investor “Top 5 for ‘25” On-Demand Conference
Mittwoch 19 Februar 2025 (3 Wochen vor) • GlobeNewswire Inc.

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Freitag 14 Februar 2025 (3 Wochen vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Donnerstag 13 Februar 2025 (3 Wochen vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Donnerstag 13 Februar 2025 (3 Wochen vor) • Edgar (US Regulatory)

Palisade Bio Presents Positive Preclinical Data of PALI-2108 for the Treatment of Ulcerative Colitis
Montag 10 Februar 2025 (4 Wochen vor) • GlobeNewswire Inc.

Palisade Bio Selected for Poster Presentation at the 2025 Crohn’s & Colitis Congress
Mittwoch 29 Januar 2025 (1 Monat vor) • GlobeNewswire Inc.

Palisade Bio to Present at LIVE! with Webull Corporate Connect: Healthcare Investment Webinar
Mittwoch 22 Januar 2025 (2 Monate vor) • GlobeNewswire Inc.

Palisade Bio Completes All Five SAD Cohorts and Advances to MAD Cohorts of Phase 1a/b Study of PALI-2108 for Treatment of Ulcerative Colitis
Donnerstag 16 Januar 2025 (2 Monate vor) • GlobeNewswire Inc.

Palisade Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Freitag 3 Januar 2025 (2 Monate vor) • GlobeNewswire Inc.

Form 424B3 - Prospectus [Rule 424(b)(3)]
Dienstag 17 Dezember 2024 (3 Monate vor) • Edgar (US Regulatory)

Weitere Palisade Bio Inc News-Artikel

Vontobel Financial Produ...

Intesa Sanpaolo

Fidelity MSCI Communicat...

Schwab International Equ...

Societe Generale Effekten

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen